Skip to main content
. 2012 Jul 23;12:215. doi: 10.1186/1472-6963-12-215

Table 2.

Health insurance characteristics

 
Breast cancer
Carboplatin-treated lung cancer
Cisplatin-treated lung cancer
  All Older 5-HT3RAs Palonosetron P All Older 5-HT3RAs Palonosetron P All Older 5-HT3RAs Palonosetron P
N
3,606
1,742
1,864
 
4,497
2,691
1,806
 
1,154
764
390
 
Type of payer (%)
 
 
 
NS
 
 
 
NS
 
 
 
NS
Commercial
3,321 (92.1)
1,592 (91.4)
1,729 (92.8)
 
3,632 (80.8)
2,149 (79.9)
1,483 (82.1)
 
971 (84.1)
638 (83.5)
333 (85.4)
 
Public
167 (4.6)
87 (5.0)
80 (4.3)
 
715 (15.9)
448 (16.7)
267 (14.8)
 
121 (10.5)
81 (10.6)
40 (10.3)
 
Self-insured
100 (2.8)
54 (3.1)
46 (2.5)
 
134 (3.0)
84 (3.1)
50 (2.8)
 
55 (4.8)
39 (5.1)
16 (4.1)
 
Unknown
18 (0.5)
9 (0.5)
9 (0.5)
 
16 (0.4)
10 (0.4)
6 (0.3)
 
7 (0.6)
6 (0.8)
1 (0.3)
 
Type of plan (%)
 
 
 
<0.0001
 
 
 
<0.0001
 
 
 
NS
HMO
813 (22.6)
434 (24.9)
379 (20.3)
 
1,071 (23.8)
734 (27.3)
337 (18.7)
 
272 (23.6)
182 (23.8)
90 (23.1)
 
Indemnity
320 (8.9)
136 (7.8)
184 (9.9)
 
854 (19.0)
499 (18.5)
355 (19.7)
 
170 (14.7)
112 (14.7)
58 (14.9)
 
PPO
1,742 (48.3)
792 (45.5)
950 (51.0)
 
1,982 (44.1)
1,114 (41.4)
868 (48.1)
 
551 (47.8)
360 (47.1)
191 (49.0)
 
POS
556 (15.4)
316 (18.1)
240 (12.9)
 
462 (10.3)
278 (10.3)
184 (10.2)
 
120 (10.4)
77 (10.1)
43 (11.0)
 
Other
175 (4.9)
64 (3.7)
111 (6.0)
 
128 (2.9)
66 (2.5)
62 (3.4)
 
41 (3.6)
33 (4.3)
8 (2.1)
 
Pharmacy benefit (%)
 
 
 
0.0008
 
 
 
<0.0001
 
 
 
NS
No
700 (19.4)
300 (17.2)
400 (21.5)
 
1,229 (27.3)
656 (24.4)
573 (31.7)
 
246 (21.3)
151 (19.8)
95 (24.4)
 
Yes
2,372 (65.8)
1,198 (68.8)
1,174 (63.0)
 
2,809 (62.5)
1,769 (65.7)
1,040 (57.6)
 
761 (65.9)
518 (67.8)
243 (62.3)
 
Unknown 534 (14.8) 244 (14.0) 290 (15.6)   459 (10.2) 266 (9.9) 193 (10.7)   147 (12.7) 95 (12.4) 52 (13.3)  

HMO: health maintenance organization, PPO: preferred provider organization, POS: point of service, pts: patients.